| Trial ID: | L3401 |
| Source ID: | NCT00947024
|
| Associated Drug: |
10 Mg Glipizide Tablet (Geneva Pharmaceutical, Inc.), Administered Immediately After A Standard Breakfast.
|
| Title: |
To Demonstrate the Effect of Food on the Bioavailability of Glipizide
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: 10 mg Glipizide Tablet (Geneva Pharmaceutical, Inc.), Administered Immediately After a Standard Breakfast.|DRUG: 10 mg Glucotrol Tablet (Roerig), Administered Immediately After a Standard Breakfast.|DRUG: 10 mg Glipizide Tablet (Geneva Pharmaceutical, Inc.), Administered After an Overnight Fast.
|
| Outcome Measures: |
Primary: Bioequivalence based on AUC and Cmax, 15 days |
|
| Sponsor/Collaborators: |
Sponsor: Sandoz
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
18
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
1993-11
|
| Completion Date: |
1993-11
|
| Results First Posted: |
|
| Last Update Posted: |
2017-03-28
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00947024
|
